Fig. 2
From: Inhibition of TGF-β signaling enhances osteogenic potential of iPSC-derived MSCs
Surface marker expression during iMSC-differentiation. Expression of (A) iPSC-markers (CD326, SSEA-4, SSEA-4, Tra-1-60, Tra-1-81) and (B) of MSC-markers (CD44, CD73, CD90, CD105) was measured by flow cytometry. Percentages of positive cells from iPSCs (red) and iMSCs differentiated with (green) and without SB (blue) at different passages of the iMSC differentiation process. Means and standard deviations are displayed and were compared by one-way ANOVA and Tuckey’s multiple comparison test (n ≥ 7, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001; # indicate significant p-values compared to iPSCs).
